Ramoliya Pharma Announces Major Entry Into the Generic Medicine Market
Ramoliya Pharmaceuticals has taken a bold step into the generic pharmaceutical sector, signaling a new phase of rapid expansion. Supported by years of trust and strong business fundamentals, the company has announced that it will be launching over 25 high-quality formulations within the year.
The brand aims to provide world-class medicines that are accessible and reliable for patients across India. Leveraging advanced manufacturing standards and a clinically driven approach, the company is preparing to compete with established leaders in the pharmaceutical industry.
Ramoliya Pharmaceuticals is a venture under the reputed parent company Akshar Selection, known for its strong national presence in the textile segment. With this entry into the healthcare sector, the group is focusing on building a future where quality healthcare is not limited by geography or financial constraints.
Company representatives stated that this expansion is not just a business decision but a commitment to creating healthier communities. The industry now awaits the launch of these formulations, marking a notable development in India’s ever-evolving pharmaceutical landscape.